Company news

AngioDynamics, Inc. news in 2026

AngioDynamics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife® IRE for Prostate and Liver Cancer

October 14, 2026

AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and Profitability

October 8, 2026

AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive Officer

October 8, 2026

AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence

October 2, 2026

AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026

September 28, 2026

Press space to expand and collapse this section AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability

July 14, 2026

AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability

July 14, 2026

AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026

June 30, 2026

AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)

June 17, 2026

AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect

May 28, 2026

AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

May 27, 2026

AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer

May 13, 2026

AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability

April 1, 2026

AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference

March 31, 2026

AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026

March 19, 2026

AngioDynamics to Present at the Leerink Partners Global Healthcare Conference

February 23, 2026

AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform

February 19, 2026

AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care

February 4, 2026

AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance

February 2, 2026

AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability

January 5, 2026

Calls in 2026

Decks in 2026